Titlebook: International Conference on Artificial Intelligence for Smart Community; AISC 2020, 17–18 Dec Conference proceedings 2022

Projection

A. Parvathi,M. Rathaiah,R. Kiranmayi,K. Nagabhushanam pharmacological testing of the selected compound in high doses in tests directed at indications other than the intended indication of the new compound. These tests were followed by pharmacokinetic studies, which were mainly aimed at confirming of a suitable half-life time and at oral activity. Safe

finite

Sai Goutm Golive,B. Vijaya Krishna,B. Parama Sivam,K. Ramash Kumar pharmacological testing of the selected compound in high doses in tests directed at indications other than the intended indication of the new compound. These tests were followed by pharmacokinetic studies, which were mainly aimed at confirming of a suitable half-life time and at oral activity. Safe

HAIRY

B. Venkata Prasanth,Raja Sathish Kumar,Vijaya Krishna Boyina,K. Ramash Kumar pharmacological testing of the selected compound in high doses in tests directed at indications other than the intended indication of the new compound. These tests were followed by pharmacokinetic studies, which were mainly aimed at confirming of a suitable half-life time and at oral activity. Safe

低三下四之人

Vertebra

S. Anitha,R. Kiranmayi,K. Nagabhushanam,K. Firdose Kowser Ahamadia in drug finding, drug development and decision making in th.Safety aspects have become an outstanding issue in the process of drug discovery and development. Until 15 years ago safety aspects were addressed by pharmacological testing of the selected compound in high doses in tests directed at indic

STAT

P. Keerthi,R. Kiranmayi,K. Nagabhushanam,K. Firdose Kowser Ahamadia in drug finding, drug development and decision making in th.Safety aspects have become an outstanding issue in the process of drug discovery and development. Until 15 years ago safety aspects were addressed by pharmacological testing of the selected compound in high doses in tests directed at indic

設(shè)想

溝通

A. Nagarajan,K. Ramash Kumar,G. Sureshkumaar pharmacological testing of the selected compound in high doses in tests directed at indications other than the intended indication of the new compound. These tests were followed by pharmacokinetic studies, which were mainly aimed at confirming of a suitable half-life time and at oral activity. Safe

初次登臺

Nesar Uddin,Md Saiful Islam,Jewel Sikder Joy,Ishaque Mozumder pharmacological testing of the selected compound in high doses in tests directed at indications other than the intended indication of the new compound. These tests were followed by pharmacokinetic studies, which were mainly aimed at confirming of a suitable half-life time and at oral activity. Safe

原告

Adamu Umar Ibrahim,Berihun Mamo Negash in drug finding, drug development and decision making in th.Safety aspects have become an outstanding issue in the process of drug discovery and development. Until 15 years ago safety aspects were addressed by pharmacological testing of the selected compound in high doses in tests directed at indic